Cafepharma Today

June 13 2025 - Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Urogen’s bladder cancer drug wins FDA approval over adcomm’s objections
A day in the life of GSK’s U.S. president
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zalicus Misses Key Secondary Endpoint
Seeking Alpha
Monday, September 10, 2012 - 1:40pm
tags:
Zalicus, Amgen, Novartis, Sanofi, Synavive, rheumatoid arthritis
J&J Settles Risperdal Lawsuit on Opening Day of Trial
Bloomberg
Monday, September 10, 2012 - 1:34pm
tags:
JNJ, settlements, Risperdal, antipsychotics
AstraZeneca halts development of anti-obesity drug
Marketwatch
Monday, September 10, 2012 - 11:23am
tags:
obesity, Palatin, AstraZeneca, AZD2820
Sun Pharma Says Things Are Improving, But…
Pharmalot
Monday, September 10, 2012 - 11:20am
tags:
Sun Pharma, drug manufacturing
Why Vascepa's NCE Status Might Still Be Unresolved This Month
Seeking Alpha
Monday, September 10, 2012 - 11:19am
tags:
NCE, Vascepa, Amarin
Is Amarin Positioned To Be A Takeover Target?
Seeking Alpha
Monday, September 10, 2012 - 11:11am
tags:
Amarin, M&A
5 Pharmaceutical Companies To Present At The Rodman And Renshaw Conference On September 11
Seeking Alpha
Monday, September 10, 2012 - 11:05am
tags:
Cellceutix, Acadia, Cell Therapeutics, Aeterna Zentaris, AcelRx
3 Companies With Exciting Phase II Trial Data Close Out 2012
Seeking Alpha
Monday, September 10, 2012 - 11:02am
tags:
Peregrine Pharmaceuticals, bavituximab, Vigabatrin, Catalyst Pharmaceutical Partners, OncoSec, NeoPulse
Cleveland BioLabs in FDA agreement on pivotal animal efficacy study for CBLB502
Yahoo/Fly on the Wall
Monday, September 10, 2012 - 10:58am
tags:
CBLB502, FDA, Cleveland BioLabs, radiation countermeasure, radiation
Amgen Joins Renault Selling Bonds to Pre-Empt Crisis Woes
Bloomberg
Monday, September 10, 2012 - 10:49am
tags:
Renault, Amgen, bonds
Why Analysts Love Teva
Seeking Alpha
Monday, September 10, 2012 - 10:47am
tags:
Amgen, JNJ, Teva Pharmaceuticals, Merck, Pfizer, Watson Pharmaceuticals
FDA Drug Review Deal Set to Unravel as Fiscal Cliff Looms
Bloomberg
Monday, September 10, 2012 - 10:44am
tags:
FDA, drug approvals
Lung Cancer Genomic Mapping Yields New Targets, Researchers Say
Bloomberg
Monday, September 10, 2012 - 10:43am
tags:
genomic mapping, lung cancer, Pfizer, Iressa, Roche, Tarceva
Teva sues Perrigo over ProAir asthma inhaler patents
Globes, Israel
Sunday, September 9, 2012 - 11:23am
tags:
Teva Pharmaceuticals, Perrigo, ProAir HFA, lawsuits, generics, Patent Infringement
Testosterone marketing frenzy draws skepticism
Yahoo/AP
Sunday, September 9, 2012 - 11:20am
tags:
testosterone, Abbott Laboratories, Watson Pharmaceuticals, Androderm, Androgel, Axiron, Eli Lilly
Why This Tiny But Profitable Biotech May Be Gobbled Up By Big Pharma
Forbes
Sunday, September 9, 2012 - 11:17am
tags:
Spectrum Pharmaceuticals
China Biotech In Review: WuXi Makes Deal To Develop Therapeutic Antibody Candidates
Seeking Alpha
Sunday, September 9, 2012 - 11:15am
tags:
China National Biotech Group, WuXi PharmaTech, China Medical Technologies, Dainippon Sumitomo
3 Things to Watch With Pfizer
Motley Fool
Sunday, September 9, 2012 - 11:13am
tags:
Pfizer
1 Emerging-Market Threat to Big Pharma
Motley Fool
Sunday, September 9, 2012 - 11:07am
tags:
generics
3 Vaccine Companies With Upcoming Catalysts
Seeking Alpha
Sunday, September 9, 2012 - 11:05am
tags:
Sinovac Biotech, Dynavax Technologies, Vical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.